SCHEMBL31157548

SCHEMBL31157548

Nc1ncc(-n2cc(C(=O)O)c(=O)c3cc(Cl)c(N4Cc5cccnc5C4)cc32)cc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PIK3CG P48736 2/20 0.40
TIPARP Q7Z3E1 1/20 0.38
GRM1 Q13255 1/20 0.36
CYP2C9 P11712 3/20 0.36
CYP3A4 P08684 2/20 0.36
TOP1 P11387 2/20 0.35
RORC P51449 2/20 0.35
POLB P06746 1/20 0.34
HSP90AA1 P07900 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MAPT P10636 1/20 0.34
CAPN1 P07384 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30298075 0.89 LMNA (0.41) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL30298024 0.87 LMNA (0.45) LMNAMEN1KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL31157585 0.85 TIPARP (0.41) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL31157413 0.84 CAPN1 (0.48) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL31157491 0.83 CAPN1 (0.43) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL30298069 0.82 GRM1 (0.41) LMNAMEN1KMT2APIK3CGTIPARP
SCHEMBL31157480 0.81 PIK3CG (0.43) LMNAMEN1KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL30298054 0.81 GRM1 (0.41) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL31157586 0.81 LMNA (0.44) LMNAMEN1KMT2AKDM4EALDH1A1
SCHEMBL31157452 0.80 PIK3CG (0.39) LMNAMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. 2024-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES PAPSS1, OTUD7B, BRD7 LMNA 3801/4885MEN1 3213/4885KMT2A 2390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.